Results 71 to 80 of about 57,049 (249)

Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1237-1245, April 2025.
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri   +12 more
wiley   +1 more source

Investigating the most cost-effective strategies to use active load control in wind turbines of various sizes

open access: yesWind Energy and Engineering Research
Active load control (ALC) is widely considered a key technology for reducing wind turbine loads, thus enabling larger and more reliable rotors. In this work, we investigate the most cost-effective utilization of ALC for wind turbines by exploring the ...
Ipsita Mishra, D. Todd Griffith
doaj   +1 more source

Alces alces

open access: yes
Alces alces (Linnaeus, 1758) – лось Описание. 2 фаланга ЗИН 39237 найдена в верхней (первой) прослойке ВГТ, она неполной сохранности. Фрагмент дистального отдела плечевой кости ЗИН 38730 обнаружен в 3-ей прослойке ВГТ (Рис. 5G 2). Ширина дистального отдела плечевой кости ЗИН 38730 – 79.0 мм, ширина блока – 73.0 мм. По размерам эта кость соответствует A.
Petrova, E. A., Bessudnov, A. A.
openaire   +2 more sources

The Effect of Curcumin (as Meriva) on Absolute Lymphocyte Count (ALC), NK Cells and T Cell Populations in Patients with Stage 0/1 Chronic Lymphocytic Leukemia

open access: yes, 2015
Purpose: To determine the effect of curcumin (as Meriva) on absolute lymphocyte count (ALC), T cell populations and NK cells in patients with Rai stage 0/1 chronic lymphocytic leukemia (CLL) over a period of six months.
T. Golombick   +3 more
semanticscholar   +1 more source

Brochure du master ALC/Licithe 2020-2021

open access: yes, 2020
Voici la brochure du Master Recherche ALC/LICITHE, avec la liste complète des séminaires pour 2020-2021.
Mathilde Lévêque
core  

ALC Video Art Festival:In Ecstasy

open access: yes, 2021
In Ecstasy is multi-screen film by Gareth Hudson shown at ALC Video Art ...
Hudson, Gareth; id_orcid
core   +2 more sources

Dexamethasone prophylaxis for excessive lymphocyte expansion after cilta-cel in multiple myeloma

open access: yesBlood Advances
: Increased absolute lymphocyte count (ALC) may predict risk of treatment-related mortality and atypical neurologic events among patients receiving chimeric antigen receptor (CAR) T-cell therapies for relapsed/refractory multiple myeloma.
Peter A. Forsberg   +7 more
doaj   +1 more source

EXPERIMENTAL STUDIES ON BRUCELLA ABORTUS IN MOOSE (ALCES ALCES) [PDF]

open access: yesJournal of Wildlife Diseases, 1996
Four moose (Alces alces) were inoculated conjunctivally with B. abortus biovar 1 to determine their susceptibility to brucellosis, and to describe the serology, bacteriology, hematology, clinical chemistry, and pathology associated with infection. All moose became infected. Two moose were killed at day 70 post-exposure, one (83F) died acutely at day 85,
L B, Forbes, S V, Tessaro, W, Lees
openaire   +2 more sources

alc-regulated genes in adult male fly heads.

open access: yes, 2019
RNA-seq data for genes regulated in response to neuronal alc knockdown Fold change in transcript levels for elav>Dcr2, alc-RNAi(KK) compared to the elav>Dcr2/+ controls.
Julie L. Hentze (278924)   +5 more
core   +1 more source

Prognostic Value of Radiation-Induced Lymphopenia in Patients with Unresectable Primary Hepatocellular Carcinoma Receiving Radiotherapy

open access: yesZhongliu Fangzhi Yanjiu
ObjectiveTo evaluate the prognostic value of radiation-induced lymphocytopenia in the survival of patients with primary hepatocellular carcinoma receiving radiation therapy. MethodsThe clinical data of 98 patients with unresectable primary hepatocellular
Jinlong TONG   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy